Patents by Inventor Virginia Chen

Virginia Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for the detection of acute rejection in heart transplantation
    Patent number: 10989716
    Abstract: The present disclosure relates to methods of diagnosing acute rejection of a cardiac allograft in a subject using genomic expression profiling, proteomic expression profiling, or both on panels of nucleic acid markers and proteomic markers.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: April 27, 2021
    Assignee: The University of British Columbia
    Inventors: Bruce McManus, Raymond Ng, Scott Tebbutt, Janet Wilson-McManus, Zsuzsanna Hollander, Karen Lam, Virginia Chen, Darlene Dai, Casey Shannon, Andrew Ignaszewski, Robert Balshaw, Robert McMaster, Paul Keown
  • Methods and systems of detecting plasma protein biomarkers for diagnosing acute exacerbation of COPD
    Patent number: 10942188
    Abstract: Described are compositions and methods for diagnosing acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Multiple reaction monitoring mass spectrometry (MRM-MS) was used to quantify the amount of protein biomarkers in plasma samples from human subjects. The amount of the biomarkers in the sample can distinguish AECOPD from a stable or convalescent state of COPD, or from a subject without COPD.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: March 9, 2021
    Assignee: The University of British Columbia
    Inventors: Don D. Sin, Raymond T. Ng, Bruce McManus, Zsuzsanna Hollander, Virginia Chen
  • METHODS AND SYSTEMS OF DETECTING PLASMA PROTEIN BIOMARKERS FOR DIAGNOSING ACUTE EXACERBATION OF COPD
    Publication number: 20190383830
    Abstract: Described are compositions and methods for diagnosing acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Multiple reaction monitoring mass spectrometry (MRM-MS) was used to quantify the amount of protein biomarkers in plasma samples from human subjects. The amount of the biomarkers in the sample can distinguish AECOPD from a stable or convalescent state of COPD, or from a subject without COPD.
    Type: Application
    Filed: May 17, 2016
    Publication date: December 19, 2019
    Inventors: Don D. Sin, Raymond T. Ng, Bruce McManus, Zsuzsanna Hollander, Virginia Chen
  • BIOMARKERS FOR THE DETECTION OF ACUTE REJECTION IN HEART TRANSPLANTATION
    Publication number: 20180164326
    Abstract: The present disclosure relates to methods of diagnosing acute rejection of a cardiac allograft in a subject using genomic expression profiling, proteomic expression profiling, or both on panels of nucleic acid markers and proteomic markers.
    Type: Application
    Filed: April 28, 2016
    Publication date: June 14, 2018
    Applicant: The University of British Columbia
    Inventors: Bruce McManus, Raymond Ng, Scott Tebbutt, Janet Wilson-McManus, Zsuzsanna Hollander, Karen Lam, Virginia Chen, Darlene Dai, Casey Shannon, Andrew Ignaszewski, Robert Balshaw, Robert McMaster, Paul Keown